QIAGEN N.V. to release results for Q1 2023 and hold webcast

Venlo, The Netherlands, April 18, 2023 - QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the first quarter 2023.

Press release date / time: Wednesday, May 3, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Thursday, May 4, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.

Three options for joining the conference call

  1. Register for call back connection - Click here:Connect meService available 15 minutes before call start
  2. Dial-inby phone U.S.: +1 929 477 0402 UK: +44 (0)330 165 3655 GER: +49 (0)69 6610 2490 Conference ID: 5702254
    To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
  3. Access the audio webcast - Click here:Access Webcast
    A conference call replay will be available by using the following link: https://globalmeet.webcasts.com/starthere.jsp?ei=1596346&tp_key=edbc0e49e6

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2022, QIAGEN employed approximately 6,200 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

Contact:

John Gilardi

Vice President, Head of Corporate Communications and Investor Relations +49 2103 29 11711

+49 152 018 11711

+1 240 686 2222 Email: ir@qiagen.com

1

Phoebe Loh

Senior Director Investor Relations +49 2103 29 11457

+49 152 018 11457 Email: ir@qiagen.com

2

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Qiagen NV published this content on 18 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 April 2023 14:27:03 UTC.